ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201,856 | -56.5% | 9,686 | -50.0% | 0.34% | -33.9% |
| Q2 2023 | $463,959 | +27.3% | 19,372 | 0.0% | 0.51% | +14.1% |
| Q1 2023 | $364,581 | +25.7% | 19,372 | +6.4% | 0.45% | +58.0% |
| Q4 2022 | $289,935 | -8.0% | 18,212 | -13.5% | 0.28% | -9.9% |
| Q3 2022 | $315,000 | -31.4% | 21,054 | -35.4% | 0.31% | -25.9% |
| Q2 2022 | $459,000 | -34.5% | 32,597 | +12.6% | 0.42% | -16.9% |
| Q1 2022 | $701,000 | +36.1% | 28,954 | +31.2% | 0.51% | +43.7% |
| Q4 2021 | $515,000 | – | 22,075 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |